Rocky Mountain Cancer Centers-Penrose — Colorado Springs, Colorado

Rocky Mountain Cancer Centers-Penrose is a clinical research site located in Colorado Springs, Colorado, United States 80907.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers-Penrose has participated in 230 clinical trials with 152 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Colorado Springs

Browse all research sites in Colorado · View every site in Colorado Springs

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers-Penrose?

Rocky Mountain Cancer Centers-Penrose has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers-Penrose conducted?

Rocky Mountain Cancer Centers-Penrose has 230 clinical trials on record, with 152 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Rocky Mountain Cancer Centers-Penrose accredited by Crixeo Clinical Trials?

Rocky Mountain Cancer Centers-Penrose has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers-Penrose?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.